These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3874249)

  • 1. The role of Langerhans cells in antigen presentation.
    Katz SI; Cooper KD; Iijima M; Tsuchida T
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):96s-98s. PubMed ID: 3874249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
    Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
    J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Langerhans cells and keratinocytes in epidermal immunity.
    Choi KL; Sauder DN
    J Leukoc Biol; 1986 Mar; 39(3):343-58. PubMed ID: 2418143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
    Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
    J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirements for class II MHC antigen in human T cell activation.
    Goeken NE; Eckerle MK; Lioubin PJ; Staggs TS
    Transplantation; 1984 Dec; 38(6):714-9. PubMed ID: 6438845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presenting capacity of Langerhans cells from rat oral epithelium.
    Hasséus B; Dahlgren U; Bergenholtz G; Jontell M
    J Oral Pathol Med; 1995 Feb; 24(2):56-60. PubMed ID: 7745542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migration of murine epidermal Langerhans cells to regional lymph nodes: engagement of major histocompatibility complex class II antigens induces migration of Langerhans cells.
    Yamashita K; Yano A
    Microbiol Immunol; 1994; 38(7):567-74. PubMed ID: 7968691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells.
    Bjercke S; Braathen L; Gaudernack G; Thorsby E
    Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice.
    Hauser C; Katz SI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5625-8. PubMed ID: 2969593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Langerhans cells and Thy. 1+ effector cells in herpes simplex virus-1 infection in the skin of newborn mice.
    Sprecher E; Becker Y
    Arch Virol; 1988; 100(3-4):285-92. PubMed ID: 3261161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of glucocorticosteroids on epidermal cell-induced immune responses.
    Aberer W; Stingl L; Pogantsch S; Stingl G
    J Immunol; 1984 Aug; 133(2):792-7. PubMed ID: 6610710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
    Schuler G; Steinman RM
    J Exp Med; 1985 Mar; 161(3):526-46. PubMed ID: 3871837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.